UBU5:F:F-UBS (Irl) ETF Public Limited Company - MSCI USA Value UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 109.92

Change

-0.66 (-0.60)%

Market Cap

USD 0.43B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-15 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

-0.22 (-0.80%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

-0.42 (-0.82%)

USD 114.95B
SXR8:F iShares Core S&P 500 UCITS ETF..

-9.16 (-1.53%)

USD 98.13B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

N/A

USD 91.82B
XDNY:F Xtrackers MSCI Japan ESG Scree..

-0.10 (-0.63%)

USD 54.47B
VUSA:F Vanguard Funds Public Limited ..

-1.74 (-1.62%)

USD 51.63B
VUAA:F Vanguard S&P 500 UCITS Acc

-1.69 (-1.57%)

USD 51.63B
SXRZ:F iShares VII PLC - iShares Nikk..

-3.70 (-1.56%)

USD 50.58B
XJSE:F Xtrackers II - Japan Governmen..

+0.08 (+1.05%)

USD 40.89B
0ZC:F Zscaler Inc

-8.14 (-4.11%)

USD 37.92B

ETFs Containing UBU5:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 21.98% 80% B- 73% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 21.98% 79% B- 71% C-
Trailing 12 Months  
Capital Gain 29.38% 81% B- 73% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 29.38% 79% B- 70% C-
Trailing 5 Years  
Capital Gain 50.04% 76% C+ 72% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 50.04% 76% C+ 69% C-
Average Annual (5 Year Horizon)  
Capital Gain 11.08% 75% C 70% C-
Dividend Return 11.08% 73% C 63% D
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 14.18% 45% F 80% B-
Risk Adjusted Return 78.14% 84% B 87% B+
Market Capitalization 0.43B 60% D- 47% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.